Esther Vorovich
Overview
Explore the profile of Esther Vorovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
774
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khalife W, Kanwar M, Abraham J, Li S, John K, Sinha S, et al.
J Card Fail
. 2024 Oct;
30(10):1196-1207.
PMID: 39389726
Cardiogenic shock (CS) is a hemodynamic syndrome that can progress to systemic metabolic derangements and end-organ dysfunction. Prior studies have reported hemodynamic parameters at the time of admission to be...
2.
Ton V, Li S, John K, Li B, Zweck E, Kanwar M, et al.
J Am Coll Cardiol
. 2024 Sep;
PMID: 39217545
Background: The Cardiogenic Shock Working Group-modified Society for Cardiovascular Angiography and Interventions (CSWG-SCAI) staging was developed to risk stratify cardiogenic shock (CS) severity. Data showing progressive changes in SCAI stages...
3.
Vallabhajosyula S, Faugno A, Li B, John K, Kong Q, Sinha S, et al.
J Card Fail
. 2024 Jul;
30(11):1516-1521.
PMID: 39002848
No abstract available.
4.
Kochar A, Vallabhajosyula S, John K, Sinha S, Esposito M, Pahuja M, et al.
J Heart Lung Transplant
. 2024 Jun;
43(11):1846-1856.
PMID: 38944132
Background: There are limited data depicting the prevalence and ramifications of acute limb ischemia (ALI) among cardiogenic shock (CS) patients. Methods: We employed data from the Cardiogenic Shock Working Group...
5.
Sinha S, Pahuja M, Kataria R, Blumer V, Hernandez-Montfort J, Kanwar M, et al.
JACC Adv
. 2024 Jun;
2(3):100314.
PMID: 38939594
Background: Cardiogenic shock is a leading cause of mortality in patients with acute myocardial infarction. Objectives: The authors sought to compare clinical characteristics, hospital trajectory, and drug and device use...
6.
Fried J, Farr M, Kanwar M, Uriel N, Hernandez-Montfort J, Blumer V, et al.
J Heart Lung Transplant
. 2024 Jun;
43(9):1478-1488.
PMID: 38834162
Background: The Impella 5.0 and 5.5 pumps (Abiomed, Danvers, MA) are large-bore transvalvular micro-axial assist devices used in cardiogenic shock (CS) for patients requiring high-capacity flow. Despite their increasing use,...
7.
Kanwar M, Billia F, Randhawa V, Cowger J, Barnett C, Chih S, et al.
J Heart Lung Transplant
. 2023 Dec;
43(2):189-203.
PMID: 38069920
In recent years, there have been significant advancements in the understanding, risk-stratification, and treatment of cardiogenic shock (CS). Despite improved pharmacologic and device-based therapies for CS, short-term mortality remains as...
8.
Baran D, Billia F, Randhawa V, Cowger J, Barnett C, Chih S, et al.
J Heart Lung Transplant
. 2023 Dec;
43(2):204-216.
PMID: 38069919
The last decade has brought tremendous interest in the problem of cardiogenic shock. However, the mortality rate of this syndrome approaches 50%, and other than prompt myocardial revascularization, there have...
9.
Ton V, Kanwar M, Li B, Blumer V, Li S, Zweck E, et al.
JACC Heart Fail
. 2023 Nov;
11(12):1742-1753.
PMID: 37930289
Background: Studies reporting cardiogenic shock (CS) outcomes in women are scarce. Objectives: The authors compared survival at discharge among women vs men with CS complicating acute myocardial infarction (AMI-CS) and...
10.
Garan A, Kataria R, Li B, Sinha S, Kanwar M, Hernandez-Montfort J, et al.
J Card Fail
. 2023 Oct;
30(4):564-575.
PMID: 37820897
Background: Consensus recommendations for cardiogenic shock (CS) advise transfer of patients in need of advanced options beyond the capability of "spoke" centers to tertiary/"hub" centers with higher capabilities. However, outcomes...